版本:
中国

BRIEF-Aeglea Biotherapeutics Q1 revenue $1.0 mln vs $900,000

May 9 Aeglea Bio Therapeutics Inc

* Aeglea biotherapeutics provides corporate update and reports first quarter 2017 financial results

* Q1 revenue $1.0 million versus $900,000

* Q1 revenue view $1.7 million -- Thomson Reuters I/B/E/S

* Aeglea bio therapeutics inc - net loss totaled $6.2 million and $4.5 million for q1 of 2017 and 2016, respectively

* Aeglea bio therapeutics inc - at march 31, 2017, aeglea had available cash, cash equivalents and marketable securities of $57.9 million Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐